These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 11481973)

  • 1. [Possible relevance of alterations at the cellular, neuronal connectivity and brain structure levels to the pathophysiology of schizophrenia].
    Berger E; Shiloh R; Weizman A; Munitz H
    Harefuah; 2001 Jul; 140(7):648-52. PubMed ID: 11481973
    [No Abstract]   [Full Text] [Related]  

  • 2. Significance of dysfunctional glutamatergic transmission for the development of psychotic symptoms.
    Pietraszek M
    Pol J Pharmacol; 2003; 55(2):133-54. PubMed ID: 12926541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Schizophrenia: receptors and clinical aspects].
    Azorin JM
    Encephale; 1997 Apr; 23 Spec No 2():17-9. PubMed ID: 9273301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The neurochemical circuitry of schizophrenia.
    Carlsson A
    Pharmacopsychiatry; 2006 Feb; 39 Suppl 1():S10-4. PubMed ID: 16508890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain volume changes in schizophrenia: how do they arise? What do they mean?
    Lewis DA
    Psychol Med; 2009 Nov; 39(11):1779-80. PubMed ID: 19379533
    [No Abstract]   [Full Text] [Related]  

  • 6. Integrating the neurobiology of schizophrenia. Preface.
    Abi-Dargham A; Guillin O
    Int Rev Neurobiol; 2007; 78():xiii-xvi. PubMed ID: 17349855
    [No Abstract]   [Full Text] [Related]  

  • 7. Alterations of serotonin transmission in schizophrenia.
    Abi-Dargham A
    Int Rev Neurobiol; 2007; 78():133-64. PubMed ID: 17349860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipsychotic-associated neuronal changes in the brain: toxic, therapeutic, or irrelevant to the long-term outcome of schizophrenia?
    Dean CE
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):174-89. PubMed ID: 16376473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neurobiology of cognition in schizophrenia.
    Tamminga CA
    J Clin Psychiatry; 2006; 67 Suppl 9():9-13; discussion 36-42. PubMed ID: 16965183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of antipsychotic treatment on cerebral structure and function in schizophrenia.
    Vita A; De Peri L
    Int Rev Psychiatry; 2007 Aug; 19(4):429-36. PubMed ID: 17671875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent concepts in clinical psychiatry: drug treatment in schizophrenia.
    Hussain SH
    J Pak Med Assoc; 1991 Sep; 41(9):229-34. PubMed ID: 1683911
    [No Abstract]   [Full Text] [Related]  

  • 12. Recent advances in the neurobiology of schizophrenia.
    Miyamoto S; LaMantia AS; Duncan GE; Sullivan P; Gilmore JH; Lieberman JA
    Mol Interv; 2003 Feb; 3(1):27-39. PubMed ID: 14993436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of white matter for the pathophysiology of schizophrenia.
    Brambilla P; Tansella M
    Int Rev Psychiatry; 2007 Aug; 19(4):459-68. PubMed ID: 17671878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neuronal plasticity of schizophrenia].
    Crocq MA
    Encephale; 2007 Jun; 33 Pt 3():S402-7. PubMed ID: 19101360
    [No Abstract]   [Full Text] [Related]  

  • 15. [First and second generation antipsychotics and morphological and neurochemical brain changes in schizophrenia. Review of magnetic resonance imaging and proton spectroscopy findings].
    Szulc A
    Psychiatr Pol; 2007; 41(3):329-38. PubMed ID: 17900049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neurodevelopmental theories of schizophrenia--preclinical studies].
    Lehner M; Taracha E; Wisłowska A; Zienowicz M; Maciejak P; Skórzewska A; Płaźnik A
    Psychiatr Pol; 2003; 37(4):627-39. PubMed ID: 14560492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Physiopathology of schizophrenia. Some biologic aspects].
    Tissot R
    Schweiz Arch Neurol Neurochir Psychiatr; 1984; 135(1):29-40. PubMed ID: 6148787
    [No Abstract]   [Full Text] [Related]  

  • 18. Schizophrenia: diverse approaches to a complex disease.
    Sawa A; Snyder SH
    Science; 2002 Apr; 296(5568):692-5. PubMed ID: 11976442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developmental disruptions in neural connectivity in the pathophysiology of schizophrenia.
    Karlsgodt KH; Sun D; Jimenez AM; Lutkenhoff ES; Willhite R; van Erp TG; Cannon TD
    Dev Psychopathol; 2008; 20(4):1297-327. PubMed ID: 18838043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of oxidative stress-mediated neuropathology and improved clinical outcome by adjunctive use of a combination of antioxidants and omega-3 fatty acids in schizophrenia.
    Mahadik SP; Pillai A; Joshi S; Foster A
    Int Rev Psychiatry; 2006 Apr; 18(2):119-31. PubMed ID: 16777666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.